Implementation and Evaluation of the Pathway Platform: A Digitally Enabled Care Pathway to Improve Depression Management in Primary Care
Presenter/Author Information
Ramona Donovan MS, Advocate Aurora Research Institute, Advocate HealthFollow
Rasha Khatib PhD, MHS, Advocate Aurora Research Institute, Advocate HealthFollow
Christopher Blair MS, Takeda Pharmaceuticals U.S.A, Inc
Maggie McCue, Takeda Pharmaceuticals U.S.A, Inc
Ben Fehnert Cognition Kit, Cambridge, UK and Ctrl Group, Fora Health, London, UK
James King, Ctrl Group/Fora Health, London, UK
Michael Martin, Takeda Pharmaceuticals U.S.A., Inc
Marybeth Ingle PhD, MPH, Advocate Aurora Research Institute, Advocate HealthFollow
Iridian Guzman MPH, Advocate Aurora Research Institute, Advocate HealthFollow
David Kemp MD, Behavioral Health, Advocate Christ Medical Center, Advocate HealthFollow
Recommended Citation
Donovan R, Khatib R, Blair C, et al. Implementation and Evaluation of the Pathway Platform: A Digitally Enabled Care Pathway to Improve Depression Management in Primary Care. J Patient Cent Res Rev. 2024;11:238-239. doi: 10.17294/2330-0698.2137
Presentation Notes
Oral presentation at Scientific Day; May 22, 2024; Milwaukee, WI. https://institutionalrepository.aah.org/sciday/2024/oral1/6/
Link to Full Text
Open Access
Available to all.
DOWNLOADS
Since October 21, 2024
COinS
Oct 15th, 12:00 AM
Implementation and Evaluation of the Pathway Platform: A Digitally Enabled Care Pathway to Improve Depression Management in Primary Care
Affiliations
Advocate Aurora Research Institute, Advocate Christ Medical Center